TRUP TRUPANION, INC.

Nasdaq Hospital & Medical Service Plans DE CIK: 0001371285
AI RATING
BUY
68% Confidence

Investment Thesis

Trupanion demonstrates a significant profitability inflection with net income up 301.7% YoY and 11.9% revenue growth, supported by a conservative balance sheet (0.25x debt/equity) and positive free cash flow generation. However, extremely thin operating margins (1.2%), negligible returns on equity (1.2%), and limited interest coverage (2.5x) indicate structural profitability challenges that must improve for the investment thesis to sustain.

Strengths

  • + Exceptional profitability turnaround: 301.7% YoY net income growth with revenue expansion of 11.9%
  • + Strong financial position: Conservative leverage (0.25x debt/equity), solid liquidity (1.73x current ratio), and $153.5M cash reserves
  • + Positive cash generation: $13.7M free cash flow with efficient capital deployment ($847K capex)

Risks

  • ! Dangerously thin margins: 1.3% net margin and 1.2% operating margin limit financial flexibility and pricing power
  • ! Structural profitability weakness: 1.2% ROE and 0.5% ROA indicate poor asset utilization and value creation
  • ! Fragile coverage metrics: 2.5x interest coverage provides minimal cushion; any operational deterioration threatens debt service capability

Key Metrics to Watch

Financial Metrics

Revenue
384.0M
Net Income
4.9M
EPS (Diluted)
$0.11
Free Cash Flow
13.7M
Total Assets
921.6M
Cash
153.5M

Profitability Ratios

Gross Margin 15.2%
Operating Margin 1.2%
Net Margin 1.3%
ROE 1.2%
ROA 0.5%
FCF Margin 3.6%

Balance Sheet & Liquidity

Current Ratio
1.73x
Quick Ratio
1.73x
Debt/Equity
0.25x
Debt/Assets
57.2%
Interest Coverage
2.55x
Long-term Debt
99.3M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-06T19:06:51.140191 | Data as of: 2026-03-31 | Powered by Claude AI